c-Rel anticorps (C-Term)

N° du produit ABIN545357

Détail du produit anti-c-Rel anticorps

Antigène: c-Rel (REL proto-oncogene (c-Rel))

Épitope: C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp c-Rel est non-conjugé

Application: Western Blotting (WB), ELISA

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of REL.

Réactivité croisée: Humain, Souris

Immunogène: A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human REL.

Information d'application

Indications d'application: ELISA (1:1000)
Western Blot (1:100-500)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-c-Rel (ABIN545357)

Houldsworth, Olshen, Cattoretti, Donnelly, Teruya-Feldstein, Qin, Palanisamy, Shen, Dyomina, Petlakh, Pan, Zelenetz, Dalla-Favera, Chaganti: "Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas." dans: Blood, Vol. 103, Issue 5, pp. 1862-8, (2004) (PubMed).

Xiao, Shen, Hedvat, Moskowitz, Sussman, Filippa, Zelenetz, Houldsworth, Chaganti, Teruya-Feldstein: "Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma." dans: Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry, Vol. 12, Issue 3, pp. 211-5, (2004) (PubMed).

Jain, Ma, Lopez-Granados, Means, Brady, Orange, Liu, Holland, Derry: "Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation." dans: The Journal of clinical investigation, Vol. 114, Issue 11, pp. 1593-602, (2004) (PubMed).

Détails sur c-Rel

Antigène: c-Rel (REL proto-oncogene (c-Rel))

Autre désignation: REL (c-Rel Produits)

Synonymes: anticorps C-Rel, anticorps c-Rel, anticorps NFkB, anticorps c-rel, anticorps zgc:100833, anticorps Xrel2, anticorps Xrel3, anticorps rel, anticorps rel-A, anticorps rel2, anticorps rel3, anticorps v-rel, anticorps xrel, anticorps REL proto-oncogene, NF-kB subunit, anticorps reticuloendotheliosis oncogene, anticorps RELA proto-oncogene, NF-kB subunit, anticorps v-rel avian reticuloendotheliosis viral oncogene homolog, anticorps v-rel avian reticuloendotheliosis viral oncogene homolog L homeolog, anticorps ribonuclease A family member 2 pseudogene, anticorps REL, anticorps Rel, anticorps Rela, anticorps rel, anticorps rel.L, anticorps ECRP

ID gène: 5966